Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards' percutaneous heart valve trial restarts

This article was originally published in Clinica

Executive Summary

Getting back on track with its US development programme for a heart valve that can be delivered percutaneously, Edwards Lifesciences has gained the all-clear to restart a feasibility trial of the product. In addition, an investigational tool that will enable the valve to be implanted through a mini-incision between the ribs, rather than through the patient's circulatory system, has proved successful in a human trial, the company has reported.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058111

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel